1. Home
  2. ONB vs CYTK Comparison

ONB vs CYTK Comparison

Compare ONB & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONB

Old National Bancorp

HOLD

Current Price

$25.88

Market Cap

10.2B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$76.81

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONB
CYTK
Founded
1834
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
10.7B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
ONB
CYTK
Price
$25.88
$76.81
Analyst Decision
Buy
Strong Buy
Analyst Count
12
19
Target Price
$27.25
$89.26
AVG Volume (30 Days)
3.9M
1.8M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
2.46%
N/A
EPS Growth
6.55
N/A
EPS
0.59
N/A
Revenue
$125,616,000.00
$13,368,000.00
Revenue This Year
$27.93
$7.37
Revenue Next Year
$5.10
$310.19
P/E Ratio
$43.92
N/A
Revenue Growth
6.07
N/A
52 Week Low
$19.39
$35.22
52 Week High
$27.36
$88.31

Technical Indicators

Market Signals
Indicator
ONB
CYTK
Relative Strength Index (RSI) 40.89 47.22
Support Level $25.55 $73.95
Resistance Level $26.17 $79.66
Average True Range (ATR) 0.44 2.72
MACD -0.15 -0.06
Stochastic Oscillator 11.52 45.62

Price Performance

Historical Comparison
ONB
CYTK

About ONB Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: